Rare diseases
Investigational molecules
Locations
1 Main Street Ste 7, 02142-1599, United States
Clinical research includes primary biliary cholangitis and primary sclerosing cholangitis, with attention to liver-related symptoms, biochemical markers, and longer-term disease control in adults.
The sponsor’s portfolio in this area reflects a focus on conditions that affect bile flow, hepatic inflammation, and progression to advanced liver disease.
Ipsen Bioscience Inc. runs clinical trials in conditions such as Primary biliary cholangitis, Cholangitis sclerosing, Pancreatic carcinoma metastatic, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Belgium
Austria
Czechia
Germany
SpainIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
